Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.

Phase 4 Completed 39 enrolled Takeda

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the efficacy of pioglitazone compared to glibenclamide, once daily (QD), taken together with metformin and lifestyle modification in type 2 diabetic subjects with cardiovascular disease.

Timeline

Start: 2009-03
Primary completion: 2011-05
Completion: 2011-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Glyburide	Small molecule	10 mg	Oral
Subject	Pioglitazone	Small molecule	30 mg	Oral
Background	Metformin	Small molecule	—	—

Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.

Summary

Timeline

Drugs

Indications